Signal- and development-dependent alternative splicing of LEF1 in T cells is controlled by CELF2

Molecular and Cellular Biology

Volumn 31, Issue 11, 2011, Pages 2184-2195

  Mallory, Michael J ^a   Jackson, Jason ^a   Weber, Brittany ^a   Chi, Anthony ^a   Heyd, Florian ^a   Lynch, Kristen W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; PROTEIN; PROTEIN CELF2; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXON; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; EXONS; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA-BINDING PROTEINS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; THYMUS GLAND;

EID: 79958050339     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05170-11     Document Type: Article

References (40)

1. An, P., and P. J. Grabowski. 2007. Exon silencing by UAGG motifs in response to neuronal excitation. PLoS Biol. 5:e36.
2. Arce, L., N. N. Yokoyama, and M. L. Waterman. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25:7492-7504.
3. Balmelle, N., N. Zamarreno, M. S. Krangel, and C. Hernandez-Munain. 2004. Developmental activation of the TCR alpha enhancer requires functional collaboration among proteins bound inside and outside the core enhancer. J. Immunol. 173:5054-5063.
4. Bruhn, L., A. Munnerlyn, and R. Grosschedl. 1997. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev. 11:640-653.
5. Carlsson, P., M. L. Waterman, and K. A. Jones. 1993. The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes Dev. 7:2418-2430.
6. Chen, X., et al. 2006. The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol. Cell. Biol. 26:4462-4473.
7. Chou, M. Y., J. G. Underwood, J. Nikolic, M. H. Luu, and D. L. Black. 2000. Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell 5:949-957.
8. Dembowski, J. A., and P. J. Grabowski. 2009. The CUGBP2 splicing factor regulates an ensemble of branchpoints from perimeter binding sites with implications for autoregulation. PLoS Genet. 5:e1000595.
9. Faustino, N. A., and T. A. Cooper. 2005. Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol. 25:879-887.
10. Ghogomu, S. M., S. van Venrooy, M. Ritthaler, D. Wedlich, and D. Gradl. 2006. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factordriven transcription. J. Biol. Chem. 281:1755-1764.
11. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995-1008.
12. Goers, E. S., R. B. Voelker, D. P. Gates, and J. A. Berglund. 2008. RNA binding specificity of Drosophila muscleblind. Biochemistry 47:7284-7294.
13. Goo, Y. H., and T. A. Cooper. 2009. CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA. Nucleic Acids Res. 37:4275-4286.
14. Hartmann, B., et al. 2009. Global analysis of alternative splicing regulation by insulin and wingless signaling in Drosophila cells. Genome Biol. 10:R11.
15. House, A. E., and K. W. Lynch. 2008. Regulation of alternative splicing: more than just the ABCs. J. Biol. Chem. 283:1217-1221.
16. Hui, J., K. Stangl, W. S. Lane, and A. Bindereif. 2003. HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat. Struct. Biol. 10:33-37.
17. Ip, J. Y., et al. 2007. Global analysis of alternative splicing during T-cell activation. RNA 13:563-572.
18. Kalsotra, A., K. Wang, P. F. Li, and T. A. Cooper. 2010. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 24:653-658.
19. Ke, S., and L. A. Chasin. 2010. Intronic motif pairs cooperate across exons to promote pre-mRNA splicing. Genome Biol. 11:R84.
20. Ladd, A. N., N. Charlet, and T. A. Cooper. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21:1285-1296.
21. Lee, J. A., et al. 2007. Depolarization and CaM kinase IV modulate NMDA receptor splicing through two essential RNA elements. PLoS Biol. 5:e40.
22. Leiden, J. M., and C. B. Thompson. 1994. Transcriptional regulation of T-cell genes during T-cell development. Curr. Opin. Immunol. 6:231-237.
23. Leroy, O., et al. 2006. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J. Neurosci. Res. 84:852-859.
24. Lynch, K. W., and A. Weiss. 2000. A model system for the activation-induced alternative splicing of CD45 implicates protein kinase C and Ras. Mol. Cell. Biol. 20:70-80.
25. Melton, A. A., J. Jackson, J. Wang, and K. W. Lynch. 2007. Combinatorial control of signal-induced exon repression by hnRNP L and PSF. Mol. Cell. Biol. 27:6972-6984.
26. Modrek, B., A. Resch, C. Grasso, and C. Lee. 2001. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29:2850-2859.
27. Motta-Mena, L. B., F. Heyd, and K. W. Lynch. 2010. Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol. Cell 29:223-234.
28. Nilsen, T. W., and B. R. Graveley. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463.
29. Okamura, R. M., et al. 1998. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8:11-20.
30. Pan, Q., O. Shai, L. J. Lee, B. J. Frey, and B. J. Blencowe. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40:1413-1415.
31. Rao, M. K., and M. F. Wilkinson. 2006. Tissue-specific and cell type-specific RNA interference in vivo. Nat. Protoc. 1:1494-1501.
32. Rosenbloom, K., et al. 2008. Phylogenomic resources at the UCSC Genome Browser. Methods Mol. Biol. 422:133-144.
33. Rothrock, C., B. Cannon, B. Hahm, and K. W. Lynch. 2003. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45. Mol. Cell 12:1317-1324.
34. Rothrock, C. R., A. E. House, and K. W. Lynch. 2005. HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J. 24:2792-2802.
35. Tong, A., J. Nguyen, and K. W. Lynch. 2005. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons. J. Biol. Chem. 280: 38297-38304.
36. Topp, J. D., J. Jackson, A. A. Melton, and K. W. Lynch. 2008. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signalinduced repressor of CD45 variable exon 4. RNA 14:2038-2049.
37. Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific [sic] with an HMG domain, regulates T-cell receptor alpha enhancer function. Genes Dev. 5:880-894. (Erratum, 5:1113.)
38. van Genderen, C., et al. 1994. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 8:2691-2703.
39. Wang, E. T., et al. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
40. Waterman, M. L., W. H. Fischer, and K. A. Jones. 1991. A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev. 5:656-669.